Malignant neoplasm of thyroid gland. C73 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM C73 became effective on October 1, 2018.
Malignant neoplasm of thyroid gland. 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code. C73 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM …
ICD-10 Index. Neoplasms (C00–D48) Malignant neoplasms of thyroid and other endocrine glands (C73-C75) Malignant neoplasm of thyroid gland (C73) C73 - Malignant neoplasm of thyroid gland BILLABLE CODE; Malignant neoplasm of adrenal gland (C74) C74 - Malignant neoplasm of adrenal gland NON-BILLABLE CODE
Malignant neoplasm of thyroid gland ( C73) C73 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of thyroid gland. The code C73 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
Malignant neoplasm of thyroid gland BILLABLE | ICD-10 from 2011 - 2016 C73 is a billable ICD code used to specify a diagnosis of malignant neoplasm of thyroid gland. A 'billable code' is detailed enough to be used to specify a medical diagnosis. The ICD code C73 is used to code Poorly differentiated thyroid cancer
poorly differentiated thyroid carcinoma (pdtc) is malignant neoplasm of follicular cell origin showing intermediate histopathological patterns between differentiated and undifferentiated thyroid cancers.
Use Additional Code note means a second code must be used in conjunction with this code. Codes with this note are Etiology codes and must be followed by a Manifestation code or codes.
DRG Group #011-013 - Tracheostomy for face, mouth and neck diagnoses with MCC.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code C73. Click on any term below to browse the alphabetical index.
The ICD-10-CM Neoplasms Index links the below-listed medical terms to the ICD code C73. Click on any term below to browse the neoplasms index.
This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code 193 was previously used, C73 is the appropriate modern ICD10 code.
C73 is a valid billable ICD-10 diagnosis code for Malignant neoplasm of thyroid gland . It is found in the 2021 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2020 - Sep 30, 2021 .
When a specific code is not available for a condition, the Tabular List includes an NEC entry under a code to identify the code as the “other specified” code. This abbreviation is the equivalent of unspecified. This note further define, or give examples of, the content of the code or category.
NEC Not elsewhere classifiable#N#This abbreviation in the Tabular List represents “other specified”. When a specific code is not available for a condition, the Tabular List includes an NEC entry under a code to identify the code as the “other specified” code.
List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code.
An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...